Literature DB >> 21487829

Differential profile analysis of urinary cytokines in patients with overactive bladder.

Gamal Ghoniem1, Nuzhat Faruqui, Mostafa Elmissiry, Ayman Mahdy, Hassan Abdelwahab, Mathew Oommen, Asim B Abdel-Mageed.   

Abstract

INTRODUCTION AND HYPOTHESIS: We hypothesize that overactive bladder (OAB) can produce inflammatory cytokines due to afferent neural plasticity or urothelial dysfunction. This study aimed to detect abnormal cytokine levels in urine of patients with OAB compared to urinary tract infections (UTI) and controls.
METHODS: This was a prospective, single blind study including 20 premenopausal women (control), 20 with OAB and 16 with UTI. Urine samples were collected, centrifuged, and stored (-80°C). Urinary total proteins were quantified and detected by antibody-based array chip for release of 120 human cytokines in the two groups relative to the controls.
RESULTS: Majority of cytokines showed the same expression in the OAB compared with the controls. Cytokines exclusively expressed in OAB were: monocyte chemoattractant protein (MCP) 1, TARC, PARC, and Fas/TNFRSF6. MCP-2, MCP-3, tumor necrosis factor-β, GCSF and eotaxin-3 showed a shared expression in UTI and OAB. Conversely, few of the cytokines were downregulated in OAB (IL-5, IL-6, IL-7, and GM-CSF).
CONCLUSIONS: Taken together, the results suggest that a subset of inflammatory cytokines and chemokines provides a framework for development of highly optimized urinary biomarker assay for differential diagnosis and treatment of OAB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21487829     DOI: 10.1007/s00192-011-1401-8

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  29 in total

1.  Histological and neurotrophic changes triggered by varying models of bladder inflammation.

Authors:  M C Dupont; J M Spitsbergen; K B Kim; J B Tuttle; W D Steers
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

2.  Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder.

Authors:  Joon Chul Kim; Eun Young Park; Seong Il Seo; Yong Hyun Park; Tae-Kon Hwang
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

3.  Urinary cytokines as markers of reflux nephropathy.

Authors:  G K Ninan; R S Jutley; O Eremin
Journal:  J Urol       Date:  1999-11       Impact factor: 7.450

4.  Role of urothelial nerve growth factor in human bladder function.

Authors:  Lori A Birder; Amanda Wolf-Johnston; Derek Griffiths; Neil M Resnick
Journal:  Neurourol Urodyn       Date:  2007       Impact factor: 2.696

Review 5.  Human monocyte chemoattractant protein-1 (MCP-1).

Authors:  E J Leonard; T Yoshimura
Journal:  Immunol Today       Date:  1990-03

6.  Identification of interstitial cells of Cajal in human urinary bladder: concept of vesical pacemaker.

Authors:  Ahmed Shafik; Olfat El-Sibai; Ali A Shafik; Ismail Shafik
Journal:  Urology       Date:  2004-10       Impact factor: 2.649

7.  Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis.

Authors:  E M Lowe; P Anand; G Terenghi; R E Williams-Chestnut; D V Sinicropi; J L Osborne
Journal:  Br J Urol       Date:  1997-04

8.  Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function.

Authors:  W D Steers; S Kolbeck; D Creedon; J B Tuttle
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

9.  Cytokine induction in murine bladder tissue by type 1 fimbriated Escherichia coli.

Authors:  M Carbone; D L Hasty; K C Yi; J Rue; M T Fera; F La Torre; M Giannone; E Losi
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

10.  Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.

Authors:  T M de Reijke; E C de Boer; K H Kurth; D H Schamhart
Journal:  J Urol       Date:  1996-02       Impact factor: 7.450

View more
  17 in total

1.  Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls.

Authors:  Holly E Richter; Pamela Moalli; Cindy L Amundsen; Anna P Malykhina; Dennis Wallace; Rebecca Rogers; Deborah Myers; Maria Paraiso; Michael Albo; Haolin Shi; Tracy Nolen; Susie Meikle; R Ann Word
Journal:  J Urol       Date:  2017-01-13       Impact factor: 7.450

Review 2.  Fesoterodine in randomised clinical trials: an updated systematic clinical review of efficacy and safety.

Authors:  Chiara Dell'Utri; G Alessandro Digesu; Alka Bhide; Vik Khullar
Journal:  Int Urogynecol J       Date:  2012-03-13       Impact factor: 2.894

3.  What is the role for biomarkers for lower urinary tract disorders? ICI-RS 2013.

Authors:  Christopher H Fry; Arun Sahai; Bahareh Vahabi; Anthony J Kanai; Lori A Birder
Journal:  Neurourol Urodyn       Date:  2014-01-16       Impact factor: 2.696

4.  Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder.

Authors:  Long-Wang Wang; Xiao-Min Han; Chao-Hui Chen; Yan Ma; Bo Hai
Journal:  Int Urol Nephrol       Date:  2013-08-28       Impact factor: 2.370

5.  Inflammatory and tissue remodeling urinary biomarkers before and after mid urethral sling surgery for stress urinary incontinence.

Authors:  Toby C Chai; Holly E Richter; Pamela Moalli; Susan Keay; Joseph Biggio; Wenjun Zong; Teresa Curto; Hae-Young Kim; Anne M Stoddard; John W Kusek
Journal:  J Urol       Date:  2013-10-16       Impact factor: 7.450

6.  A pilot study of urine cytokines in ketamine-associated lower urinary tract symptoms.

Authors:  Rachel Y K Cheung; Jacqueline H S Lee; Symphorosa S C Chan; Dawn W T Liu; K W Choy
Journal:  Int Urogynecol J       Date:  2014-06-28       Impact factor: 2.894

7.  Differential profile analysis of urinary cytokines in patients with overactive bladder: comment.

Authors:  Rufus Cartwright; Vik Khullar; Massimo Mangino
Journal:  Int Urogynecol J       Date:  2012-08       Impact factor: 2.894

Review 8.  Biomarkers in overactive bladder.

Authors:  Alka A Bhide; Rufus Cartwright; Vik Khullar; G Alessandro Digesu
Journal:  Int Urogynecol J       Date:  2013-01-12       Impact factor: 2.894

Review 9.  Overactive bladder - 18 years - Part I.

Authors:  Jose Carlos Truzzi; Cristiano Mendes Gomes; Carlos A Bezerra; Ivan Mauricio Plata; Jose Campos; Gustavo Luis Garrido; Fernando G Almeida; Marcio Augusto Averbeck; Alexandre Fornari; Anibal Salazar; Arturo Dell'Oro; Caio Cintra; Carlos Alberto Ricetto Sacomani; Juan Pablo Tapia; Eduardo Brambila; Emilio Miguel Longo; Flavio Trigo Rocha; Francisco Coutinho; Gabriel Favre; Jose Antonio Garcia; Juan Castano; Miguel Reyes; Rodrigo Eugenio Leyton; Ruiter Silva Ferreira; Sergio Duran; Vanda Lopez; Ricardo Reges
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

10.  Expression of brain derived-neurotrophic factor and granulocyte-colony stimulating factor in the urothelium: relation with voiding function.

Authors:  Seung Mo Yuk; Ju Hyun Shin; Ki Hak Song; Yong Gil Na; Jae Sung Lim; Chong Koo Sul
Journal:  BMC Urol       Date:  2015-05-08       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.